Micelle-based nanoparticles with stimuli-responsive properties for drug delivery

Author:

Maboudi Amir Hosein1,Lotfipour Mitra Hosseini2,Rasouli Milad34,Azhdari Mohammad H.1,MacLoughlin Ronan567,Bekeschus Sander89,Doroudian Mohammad1

Affiliation:

1. Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University , Tehran , Iran

2. Department of Medical Genetics, School of Medicine, Babol University of Medical Sciences , Babol , Iran

3. Plasma Medicine Group, Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences , Jalale-Al-Ahmad Ave, 1411713137 , Tehran , Iran

4. Department of Physics, Kharazmi University , 49 Dr. Mofatteh Ave , Tehran , 15614 , Iran

5. Research and Development, Science and Emerging Technologies , Aerogen Limited, Galway Business Park , Galway , H91 HE94 , Ireland

6. School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland , Dublin , D02 YN77 , Ireland

7. School of Pharmacy and Pharmaceutical Sciences, Trinity College , Dublin , D02 PN40 , Ireland

8. ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str 2 , 17489 , Greifswald , Germany

9. Clinic and Policlinic for Dermatology and Venerology, Rostock University Medical Center , Strempelstr. 13, 18057 , Rostock , Germany

Abstract

Abstract Cancer treatment often causes adverse effects and toxicity, as chemotherapy drugs affect both cancerous and healthy cells. Scientists seek to target tumor cells specifically and minimize harm to normal cells. Smart nanoparticles (NPs) are a modern technique that can release drugs when triggered by internal or external stimuli, such as temperature, pH, ultrasound, etc. This review covers stimuli-responsive micelle-based nanoparticles (SRM-NPs), a promising drug delivery platform that can enhance drug efficacy and reduce toxicity. It discusses the recent developments and applications of SRM-NPs, their responsiveness to different stimuli, and their potential to overcome drug resistance and adaptive responses. It also addresses the challenges and issues related to their stability, reproducibility, biocompatibility, safety, and optimization. The study concludes that SRM-NPs have great potential for drug delivery, but more research and development are needed to improve their clinical utility.

Publisher

Walter de Gruyter GmbH

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3